Eli Lilly and Company
Organization details
- Legal name
- Eli Lilly and Company
- Former names
- Lilly ELI & Co Lilly ELI & Co et AL
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Indiana
- Headquarters city
- Indianapolis
- Headquarters state / province
- Indiana
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- LLY
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0000059478
- EIN
- 35-0470950
- Wikidata ID
- Q632240
Board of directors
-
Carolyn R. Bertozzi · DirectorSince 2025
-
David A. Ricks · Director · President, Chair, and CEOSince 2023
-
Gabrielle Sulzberger · DirectorSince 2023
-
J. Erik Fyrwald · DirectorSince 2023
-
Jackson P. Tai · DirectorSince 2023
-
Jamere Jackson · DirectorSince 2023
-
Jon R. Moeller · DirectorSince 2024
-
Juan R. Luciano · DirectorSince 2023
-
Karen Walker · DirectorSince 2023
-
Katherine Baicker · DirectorSince 2023
-
Kimberly H. Johnson · DirectorSince 2023
-
Marschall S. Runge · DirectorSince 2023
-
Mary Lynne Hedley · DirectorSince 2022
-
Ralph Alvarez · DirectorSince 2023
-
William G. Kaelin Jr. · DirectorSince 2023
Chief executives
Outstanding · grade A+
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 50% of the scoring weight is on file.
- Dividends 15%
- 88
- Revenue growth 20%
- 86
- Earnings growth 15%
- 100
dividend grew 13.2% a year
13.3% a year in revenue
27.5% a year in earnings per share
50% of the scoring weight is on file. Figures cover December 2016 – December 2025.
Director election results
Annual meeting of May 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
95.1%
-
96.2%
-
98.2%
-
99.8%
Board connections
11 of this board's directors also sit on 15 other boards. 4 are in the same sector.
- via David A. Ricks
-
Alnylam Pharmaceuticals Inc. Same sectorvia Carolyn R. Bertozzi
- via Juan R. Luciano
- via Ralph Alvarez
-
IQVIA Holdings Inc. Same sectorvia William G. Kaelin Jr.
- via J. Erik Fyrwald
- via Ralph Alvarez
- via Gabrielle Sulzberger
-
OmniAb Inc. Same sectorvia Carolyn R. Bertozzi
- via Jackson P. Tai
- via Karen Walker
- via Jon R. Moeller
- via Ralph Alvarez
- via Mary Lynne Hedley
-
Warby Parker Inc. Same sectorvia Gabrielle Sulzberger
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $1,259,177,809
- 126 sales by 5 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 10, 2026 | Jonsson Patrik Officer (EVP & President, LLY Int'l) | Gift | −704 | — | — |
| Nov 3, 2026 | David A. Ricks Director, Officer (President, Chair, and CEO) | Gift | −23,538 | — | — |
| Nov 2, 2026 | Hakim Anat Officer (EVP, GC & Secretary) | Open-market sale | −5,000 | $1,402.52 | $7,012,600 |
| Nov 2, 2026 | Daniel Skovronsky Officer (EVP, CS&PO & Pres. LRL) | Gift | −119 | — | — |
| Nov 1, 2026 | Brown Adrienne S Officer (EVP, President LLY Imm) | Option exercise | +2,530 | — | — |
| Nov 1, 2026 | Custer Kenneth L. Officer (EVP & President, Card Met Hlth) | Option exercise | +3,220 | — | — |
| Nov 1, 2026 | Dozier Eric Officer (EVP, Chief People Officer) | Option exercise | +2,300 | — | — |
| Nov 1, 2026 | Montarce Lucas Officer (EVP & CFO) | Option exercise | +1,610 | — | — |
| Nov 1, 2026 | Hernandez Edgardo Officer (EVP & Pres., Mfg. Operations) | Option exercise | +2,530 | — | — |
| Nov 1, 2026 | Brown Adrienne S Officer (EVP, President LLY Imm) | Shares withheld for tax | −1,099 | $1,417.54 | $1,557,389 |
| Nov 1, 2026 | Custer Kenneth L. Officer (EVP & President, Card Met Hlth) | Shares withheld for tax | −1,425 | $1,417.54 | $2,020,628 |
| Nov 1, 2026 | Dozier Eric Officer (EVP, Chief People Officer) | Shares withheld for tax | −1,019 | $1,417.54 | $1,444,985 |
| Nov 1, 2026 | Montarce Lucas Officer (EVP & CFO) | Shares withheld for tax | −678 | $1,417.54 | $960,515 |
| Nov 1, 2026 | Hernandez Edgardo Officer (EVP & Pres., Mfg. Operations) | Shares withheld for tax | −1,123 | $1,417.54 | $1,591,759 |
| Oct 19, 2026 | Ralph Alvarez Director | Grant or award | +10 | $1,240.34 | $12,417 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Eli Lilly and Company
Who is the CEO of Eli Lilly and Company?
David A. Ricks has been Eli Lilly and Company's President, Chair, and CEO since January 2017.
How many directors are on Eli Lilly and Company's board?
Eli Lilly and Company's board has 15 directors: Carolyn R. Bertozzi, David A. Ricks, Gabrielle Sulzberger, J. Erik Fyrwald, Jackson P. Tai, Jamere Jackson, Jon R. Moeller, Juan R. Luciano, Karen Walker, Katherine Baicker and 5 others.
Are Eli Lilly and Company insiders buying or selling shares?
Over the last 12 months, Eli Lilly and Company insiders made no open-market purchases and sold $1.3 billion of shares in 126 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="eli-lilly-and-company"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.